• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Sunday, November 22, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Biology

Touchscreen Task Reveals Distinct Executive Function Deficits in Parkinson’s Disease Mouse Models

by
November 20, 2026
in Biology
Reading Time: 6 mins read
0
Touchscreen Task Reveals Distinct Executive Function Deficits in Parkinson’s Disease Mouse Models

Touchscreen Task Reveals Distinct Executive Function Deficits in Parkinson’s Disease Mouse Models

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

In a comprehensive behavioral study of cognitive impairment in Parkinson’s disease, researchers demonstrated that an automated touchscreen five-choice serial reaction time task reliably identifies and differentiates executive function deficits across mouse models. Evaluating clean-grade SNCA*A53T transgenic mice and wild-type C57BL/6J controls, investigators found that transgenic mice overexpressing mutant alpha-synuclein reached peak 80 percent criterion accuracy at session 11, while wild-type animals sustained criterion performance through sessions 11 to 13, peaking at session 13. Furthermore, evaluating subacute neurotoxic injury induced by MPTP administration revealed that session 13 served as an effective operational baseline for detecting post-exposure cognitive decline. The findings demonstrate that automated touchscreen testing minimizes sensorimotor interference, providing an objective framework capable of tracking executive dysfunction driven by chronic genetic synucleinopathy and acute dopaminergic neurodegeneration.

Parkinson’s disease represents the second most prevalent neurodegenerative condition following Alzheimer’s disease, characterized pathologically by dopaminergic neuron degeneration in the substantia nigra and hallmark aggregation of alpha-synuclein into Lewy bodies. While clinical diagnoses focus on resting tremor, rigidity, and motor impairment, non-motor symptoms constitute a severe burden. Cognitive decline frequently surfaces 5 to 10 years before motor symptoms appear, sometimes advancing to dementia. Among cognitive domains, executive functions—encompassing higher-order faculties including planning, mental flexibility, self-control, working memory, attentional control, motor sequencing, and timing—suffer marked deterioration. These faculties depend on coordinated communication across distributed neural networks, particularly prefrontal cortex and basal ganglia circuits where self-control mechanisms maintain balance between action initiation and behavioral inhibition.

Evaluating executive functions in mice has long been constrained by testing limitations. Standard cognitive paradigms—including the Morris water maze, radial arm maze, T-maze, novel object recognition, and avoidance tasks—frequently encounter interference from sensorimotor deficits, physical exhaustion, anxiety, and stress. Because Parkinson’s disease models progressively develop motor abnormalities, isolating higher-order decision-making from basic physical impairments remains challenging. Touchscreen operant systems implementing the five-choice serial reaction time task address this obstacle by requiring rodents to respond to brief visual stimuli appearing pseudorandomly across five display locations. Cortical regions, especially the prefrontal cortex, are sensitive to this task. By registering responses through touch-sensitive screens, the touchscreen modality mitigates motor burdens and stress, enabling objective measurement of attentional capacity and executive performance.

To develop standardized touchscreen baselines, researchers at Xuzhou Medical University conducted experiments under ethics approval 2022095042 using seventy clean-grade male mice. The study examined forty male C57BL/6J wild-type mice weighing 20 to 23 grams and thirty male SNCA*A53T transgenic mice from Saye Model Biology Research Center. Animals were maintained in controlled quarters at 23 to 25 degrees Celsius on a twelve-hour light-dark cycle, with ad libitum food and water before behavioral protocols began. Male cohorts aged 8 to 10 weeks were utilized in testing. The transgenic strain carries the human alpha-synuclein gene harboring the A53T mutation associated with familial Parkinson’s disease loci PARK1 and PARK4, an abnormality that drives progressive motor impairment and neuropathology around one year of age.

Genotypic identification and biochemical validation were performed prior to behavioral testing to confirm model authenticity. Tail biopsies measuring 0.5 centimeters were processed in sodium hydroxide at 95 degrees Celsius, buffered with Tris-HCl, and analyzed via polymerase chain reaction systems to verify A53T transgene presence. Following decapitation on ice, midbrain tissue from three control and three A53T mice was excised to assess protein expression. Standard curves constructed on 96-well plates using bicinchoninic acid reagents and 0.5 milligram per milliliter protein standards established equal sample loading for gel electrophoresis. Western blotting and infrared imaging densitometry revealed that midbrain substantia nigra alpha-synuclein levels were significantly elevated in A53T mice compared to wild-type controls (p < 0.0001), validating the expected molecular pathology of synuclein accumulation.

Baseline physical motor ability and spatial working memory were assessed using rotarod and Y-maze apparatuses. In rotarod testing, six mice per group completed three habituation days before formal evaluation, where the drum accelerated from 4 to 40 revolutions per minute over 300 seconds. A53T transgenic mice exhibited significantly shorter drop latencies (p = 0.0002) and lower maximum speeds at falling (p < 0.0001) compared to controls, confirming balance and motor coordination deficits. Spatial working memory was evaluated in a three-arm Y-maze under quiet conditions across nine mice per cohort. Following training where one arm remained closed, testing demonstrated that A53T mice spent significantly less exploration time in the newly opened arm (p < 0.0001) and executed significantly fewer entries into that arm (p < 0.0001), confirming deficits in exploratory drive and spatial memory.

Touchscreen testing utilized the Bussey-Saksida mouse touchscreen system from Campden Instruments, featuring a trapezoidal chamber designed to focus animal attention and minimize distractions. The apparatus included modular walls, touchscreen hardware, monitoring software, and a rear food tray delivering sugar water rewards for correct responses within predetermined intervals. Prior to testing, mice underwent four monitoring days, two weeks of habituation and water restriction, and six days of sugar water preference evaluation. Mice were then acclimated to the chamber environment before entering the five-choice serial reaction time task. Beginning at session 09, visual stimuli appeared for 32 seconds and doubled in duration across subsequent sessions, while the software automatically recorded accuracy, omission rates, trace numbers, and premature responses.

Longitudinal evaluation across sessions 09 to 14 revealed distinct behavioral trajectories between genotypes. In preliminary evaluations of wild-type C57BL/6J mice, performance declined sharply after session 14, prompting researchers to establish session 13 as the terminal testing session. Wild-type controls peaked between sessions 11 and 13 at the 80 percent accuracy criterion, performing best at session 13. Conversely, fewer A53T transgenic mice achieved 80 percent accuracy, peaking earlier at session 11 before deteriorating. Accuracy frequency distribution analysis demonstrated a pronounced downward shift toward lower performance bins in A53T mice, particularly during sessions 12 and 13. Furthermore, A53T mice exhibited decreased accuracy rates, lower trace numbers, and increased punishment times compared to controls, confirming executive dysfunction.

To isolate key diagnostic indicators of executive dysfunction, researchers conducted principal component analysis and receiver operating characteristic evaluations on 5-CSRT parameters. Principal component analysis showed that the first two components accounted for 54.85 percent of variance, with PC2 vertical distribution separating transgenic and control groups more clearly than PC1. Loading plots showed that accuracy, total trials, perseverative correct responses, perseverative incorrect responses, and timeout punishment intervals conveyed similar information, suggesting future studies could reduce redundant parameters. Subsequent receiver operating characteristic analysis identified total omissions as having the strongest discriminatory power, yielding an area under the curve of 0.8234. Omission rate and accuracy rate yielded areas under the curve of 0.7333 and 0.6790 respectively, whereas timeout punished showed lower discriminatory capacity with an area of 0.5563.

To determine whether session 13 serves as a baseline for acute neurotoxicity, researchers established a subacute MPTP Parkinson’s model in C57BL/6J mice, administering 30 milligrams per kilogram intraperitoneally daily for five consecutive days. Immunofluorescence staining of substantia nigra sections with tyrosine hydroxylase antibodies and DAPI confirmed significant loss of dopaminergic neurons in MPTP-treated mice compared to controls (p = 0.0017, n = 3). In behavioral testing, mice trained up to session 13 were retested following MPTP intoxication. Retesting at session 13 revealed significant executive impairments in MPTP-treated mice, marked by notable reductions in percentage accuracy alongside increases in omission rates and premature responses. These outcomes confirmed that session 13 provides an effective baseline for capturing acute neurotoxin-induced cognitive deficits.

The authors noted that executive functions require coordinated activity across the prefrontal cortex, basal forebrain cholinergic systems, and striatal dopaminergic circuits. In Parkinson’s disease, pathological alpha-synuclein accumulation disrupts axonal projections in hippocampal-prefrontal circuitry, impairing synaptic transmission and precipitating executive dysfunction prior to extensive substantia nigra dopaminergic degeneration. The authors emphasized that coordinated circuit-level pathology, rather than isolated regional damage, drives cognitive deterioration, altering frontostriatal regulation of action and inhibition. Furthermore, while dopaminergic therapies such as levodopa can improve working memory, planning, and mental flexibility, cognitive outcomes vary across disease stages and dosages. Dopaminergic deficits are unevenly distributed across striatal regions, with medication potentially enhancing dorsal caudate tasks while impairing ventral striatal functions or provoking impulse control disorders, highlighting the complex relationship between dopamine modulation and executive processing.

The Bussey-Saksida touchscreen system provides translational relevance by mirroring human clinical assessments like the Wisconsin Card Sorting Test. In clinical neurology, the card sorting test evaluates executive dysfunction, rule learning, and cognitive shifting through choices guided by corrective feedback. The 5-CSRT employs an analogous stimulus-choice-reward framework, bridging cross-species cognitive evaluations. The authors proposed a translational diagnostic framework incorporating computerized multimodal visual stimuli with color and shape variations, response time variability tracking, and machine-learning pattern recognition. By pairing the chronic, genetically driven A53T model with the acute MPTP neurotoxic model, the study establishes a comprehensive paradigm spanning genetic and environmental factors. Establishing session 11 and session 13 baselines with an 80 percent accuracy criterion provides an objective foundation for future therapeutic interventions targeting executive dysfunction in Parkinson’s disease.

Subject of Research: Touchscreen-based behavioral assessment of executive function deficits in Parkinson's disease mouse models

Article Title: Investigate the differences in executive functions and behavioral baseline indicators of Parkinson’s disease model mice based on the five – choice serial reaction time task

Article References: Gu, H., Liao, Z., Zhou, Z., Liu, Z., Gu, M., Liang, X., Pan, H., & Tang, C. (2025). Investigate the differences in executive functions and behavioral baseline indicators of Parkinson’s disease model mice based on the five – choice serial reaction time task. Laboratory Animal Research, 41(1), Article 31. https://doi.org/10.1186/s42826-025-00262-6

Image Credits: AI Generated

DOI: 10.1186/s42826-025-00262-6

Keywords: Parkinson's disease, executive function, five-choice serial reaction time task, touchscreen behavioral analysis, SNCA A53T, MPTP model, alpha-synuclein, prefrontal cortex, substantia nigra, cognitive impairment, behavioral baseline, principal component analysis, receiver operating characteristic, tyrosine hydroxylase, rotarod test, Y-maze

News Source: Diana Fleming. (November 20, 2026). Touchscreen Task Reveals Distinct Executive Function Deficits in Parkinson’s Disease Mouse Models. Scienmag.

Tags: Alpha-synucleinbehavioral baselinecognitive impairmentexecutive functionfive-choice serial reaction time taskMPTP modelParkinson’s diseaseprefrontal cortexprincipal component analysisreceiver operating characteristicrotarod testSNCA A53Tsubstantia nigratouchscreen behavioral analysistyrosine hydroxylaseY-maze
Share12Tweet7Share2ShareShareShare1

Related Posts

STAG1 Gene Variants Impair Genome Stability and Disrupt Human Neurodevelopment

STAG1 Gene Variants Impair Genome Stability and Disrupt Human Neurodevelopment

November 22, 2026
Mutant p53 Reprograms AP-1 Complexes to Drive Cancer Cell Migration

Mutant p53 Reprograms AP-1 Complexes to Drive Cancer Cell Migration

November 22, 2026

DCAF15 and ANKIB1 Form Enzyme Complex Driving Inflammatory NLRP3 Activation

November 22, 2026

Radio Tags Alter Flight Kinematics in Neotropical Butterflies Below Standard Weight Limits

November 22, 2026

POPULAR NEWS

  • RAGE, Not TLR4, Drives Inflammatory Pain in Human Skin

    RAGE, Not TLR4, Drives Inflammatory Pain in Human Skin

    29 shares
    Share 12 Tweet 7
  • Phloem Girdling Drives Rhizosphere Microbial Adaptation to Belowground Carbon Limitation in Tobacco

    29 shares
    Share 12 Tweet 7
  • Direct Integration of GIS and AI in Tuberculosis Studies Remains Rare

    29 shares
    Share 12 Tweet 7
  • Cortical Folding Motifs Reveal Distinct Brain Shape Variations and Asymmetry From Infancy

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Tensegrity Continuum Robots Reconfigure Morphologies for Cooperative Locomotion and Manipulation

RAGE, Not TLR4, Drives Inflammatory Pain in Human Skin

Phloem Girdling Drives Rhizosphere Microbial Adaptation to Belowground Carbon Limitation in Tobacco

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 89 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.